Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.

Reu FJ, Leaman DW, Maitra RR, Bae SI, Cherkassky L, Fox MW, Rempinski DR, Beaulieu N, MacLeod AR, Borden EC.

Cancer Res. 2006 Mar 1;66(5):2785-93.

2.

Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.

Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N, MacLeod AR, Borden EC.

J Clin Oncol. 2006 Aug 10;24(23):3771-9. Epub 2006 Jun 26.

PMID:
16801630
3.
5.

IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.

Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC.

J Immunol. 2002 Jul 15;169(2):847-55.

6.

Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.

Leaman DW, Chawla-Sarkar M, Jacobs B, Vyas K, Sun Y, Ozdemir A, Yi T, Williams BR, Borden EC.

J Interferon Cytokine Res. 2003 Dec;23(12):745-56.

PMID:
14769151
7.

Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.

Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD.

Cancer Res. 2002 Jun 1;62(11):3093-9.

8.

Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.

Leaman DW, Chawla-Sarkar M, Vyas K, Reheman M, Tamai K, Toji S, Borden EC.

J Biol Chem. 2002 Aug 9;277(32):28504-11. Epub 2002 May 23.

10.

Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.

Borden EC.

Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):491-501. Epub 2007 Aug 6. Review.

12.

DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8.

Kurita S, Higuchi H, Saito Y, Nakamoto N, Takaishi H, Tada S, Saito H, Gores GJ, Hibi T.

Cancer Sci. 2010 Jun;101(6):1431-9. doi: 10.1111/j.1349-7006.2010.01565.x. Epub 2010 Mar 13.

13.

Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.

Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.

Int J Oncol. 2004 Dec;25(6):1849-57.

PMID:
15547726
14.
15.

PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.

Crowder C, Dahle Ø, Davis RE, Gabrielsen OS, Rudikoff S.

Blood. 2005 Feb 1;105(3):1280-7. Epub 2004 Sep 30.

16.

Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression.

VanOosten RL, Moore JM, Karacay B, Griffith TS.

Cancer Biol Ther. 2005 Oct;4(10):1104-12. Epub 2005 Oct 13.

PMID:
16096370
17.

Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells.

Wu XX, Kakehi Y, Mizutani Y, Nishiyama H, Kamoto T, Megumi Y, Ito N, Ogawa O.

Int J Cancer. 2003 Apr 20;104(4):409-17.

18.

TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells.

Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, Affabris E, Romeo G.

Oncogene. 2005 Apr 7;24(15):2536-46.

PMID:
15735750
19.

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.

Horak P, Pils D, Haller G, Pribill I, Roessler M, Tomek S, Horvat R, Zeillinger R, Zielinski C, Krainer M.

Mol Cancer Res. 2005 Jun;3(6):335-43.

20.

Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.

Qiu X, Zhang L, Lu S, Song Y, Lao Y, Hu J, Fan H.

Oncol Rep. 2014 Jan;31(1):202-8. doi: 10.3892/or.2013.2848. Epub 2013 Nov 14.

PMID:
24247422

Supplemental Content

Support Center